NYSE:ADCT | Profit Breakdown | ADC Therapeutics SA

Complete filed revenue-to-profit bridge showing gross profit, operating income, pre-tax income and net income.

Available history
2022-12-31 to 2026-06-30
Data captured

Historical Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2026-06-30$18.63M-$25.41M-$16.57M-$16.57M
2026-03-31$20.03M-$25.25M-$32.97M-$32.97M
2025-12-31$30.12M-$17.92M-$6.81M-$6.41M
2025-09-30$15.75M-$30.97M-$40.97M-$40.97M
2025-06-30$18.09M-$44.15M-$55.39M-$56.65M
2025-03-31$17.4M-$28.46M-$38.44M-$38.6M
2024-12-31$17.94M-$32.44M-$31.05M-$30.73M
2024-09-30$18.02M-$35.56M-$43.62M-$43.97M
2024-06-30$17.03M-$29.04M-$35.71M-$36.54M
2024-03-31$17.85M-$33.61M-$45.76M-$46.61M
2023-12-31$16.64M-$39.98M-$39.87M-$85.03M
2023-09-30$14.27M-$36.15M-$45.4M-$46.73M
2023-06-30$19.2M-$39.65M-$52.65M-$48.92M
2023-03-31$18.95M-$50.21M-$57.49M-$59.37M

Annual Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2025-12-31$81.36M-$121.5M-$141.61M-$142.62M
2024-12-31$70.84M-$130.65M-$156.14M-$157.85M
2023-12-31$69.06M-$165.99M-$195.42M-$240.05M
2022-12-31$74.91M-$123.34M-$146.82M-$157.13M